# BreCLIM-2 - A RCT Investigating Local Treatment for Breast Cancer Liver Metastases

> **NCT04079049** · PHASE3 · RECRUITING · sponsor: **Umeå University** · enrollment: 200 (estimated)

## Conditions studied

- Breast Cancer
- Liver Metastases

## Interventions

- **PROCEDURE:** Surgical intervention
- **DRUG:** Control

## Key facts

- **NCT ID:** NCT04079049
- **Lead sponsor:** Umeå University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-01-01
- **Primary completion:** 2029-12-31
- **Final completion:** 2029-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2022-05-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04079049

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04079049, "BreCLIM-2 - A RCT Investigating Local Treatment for Breast Cancer Liver Metastases". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04079049. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*